Completed × Interventional × Salivary Gland Neoplasms × Clear all Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
Phase 2 Completed
55 enrolled 10 charts
ACUPUNCTURE
Phase NA Completed
258 enrolled 16 charts
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
Phase NA Completed
114 enrolled
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
Phase 2 Completed
64 enrolled 9 charts
NAVIGATE
Phase 2 Completed
215 enrolled 3 FDA
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer
Phase 1 Completed
48 enrolled
EARN
Phase NA Completed
33 enrolled
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 2 Completed
46 enrolled
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Phase 1/2 Completed
50 enrolled 13 charts
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
Phase 2 Completed
149 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
Activity of Sorafenib in Salivary Gland Cancer
Phase 2 Completed
37 enrolled
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
19 enrolled
Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Phase 2 Completed
34 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
230 enrolled
Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Phase 2 Completed
Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Phase 2 Completed
32 enrolled
LUPSA
Phase 2 Completed
12 enrolled
DUET-2
Phase 1 Completed
150 enrolled
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Phase 1 Completed
15 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
NISCAHN
Phase 2 Completed
98 enrolled
Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Phase 2 Completed
30 enrolled 16 charts
Stereotactic Body Radiotherapy for Head and Neck Tumors
Phase 4 Completed
19 enrolled 10 charts
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
Phase 2 Completed
35 enrolled 6 charts
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Phase 1/2 Completed
70 enrolled
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase 2/3 Completed
196 enrolled 13 charts
PACSA-ORL02
Phase 2 Completed
72 enrolled
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Phase 1/2 Completed
25 enrolled 14 charts
SGC-AX14
Phase 2 Completed
26 enrolled
Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma
Phase NA Completed
7 enrolled
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
Phase 2 Completed
16 enrolled 7 charts
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase 2 Completed
34 enrolled 16 charts
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
Phase 2 Completed
16 enrolled
Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
Phase 2 Completed
29 enrolled 12 charts
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
Phase 2 Completed
18 enrolled 9 charts
PSMA-PET Imaging for Advanced ACC/SDC
Phase NA Completed
25 enrolled
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
3 enrolled
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
Phase 2 Completed
55 enrolled 8 charts
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Phase 2 Completed
23 enrolled
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Phase 2 Completed
24 enrolled
Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
Phase NA Completed
12 enrolled 10 charts
Iressa Study in Patients With Salivary Gland Cancer
Phase 2 Completed
37 enrolled 4 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 1 Completed
31 enrolled
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
Phase 2 Completed
14 enrolled
Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers
Phase 2 Completed
40 enrolled 9 charts
MAESTRO HN
Phase 2 Completed
86 enrolled 11 charts
SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
21 enrolled 10 charts
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
Phase 2 Completed
16 enrolled